Looking at itrack placement presentation in May 23, the market projection for Global Canal Surgery procedure for 2024 is about 380k at roughly $500 per procedure. If Itrack market share is 10% it is 38K sales @ $200 each (assuming it is 40:60 split for device and procedure fee), then sales $ is only $7.6Mil, so to get to $20mil revenue they need market share of 30%? Any thoughts or comments on this?
- Forums
- ASX - By Stock
- EYE
- Nova Eye Medical (EYE) Discussion
Nova Eye Medical (EYE) Discussion, page-2033
-
- There are more pages in this discussion • 1,155 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EYE (ASX) to my watchlist
|
|||||
Last
24.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $54.91M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 126021 | 24.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.0¢ | 157060 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 126021 | 0.240 |
2 | 342506 | 0.235 |
2 | 93400 | 0.230 |
3 | 75000 | 0.225 |
8 | 239721 | 0.220 |
Price($) | Vol. | No. |
---|---|---|
0.240 | 157060 | 1 |
0.245 | 100000 | 1 |
0.250 | 3996 | 1 |
0.255 | 16768 | 2 |
0.260 | 50000 | 1 |
Last trade - 08.24am 26/07/2024 (20 minute delay) ? |
Featured News
EYE (ASX) Chart |
Day chart unavailable